WVU IRB Policies
Policies
- Access to Counsel
- AE's and Unanticipated Problems (Doc 203)
- Agreements w/ other IRBs (Doc 108)
- Amendment Review (Doc 81)
- Appeal Procedures
- Audit Policy (Doc 46)
- Authority (Doc 38)
- Biohazards Policies (Doc 33)
- Communication Policies (Doc 27)
- Conflict of Interest - IRB Members (Doc 64)
- Confidentiality & Privacy (Doc 47)
- Consent Waivers (Doc 75)
- Consultants (Doc 62)
- Continuing Review Materials (Doc 79)
- Delegate Authority to RCO (Doc 220)
- DSMB Set-up and Procedures (Doc 318)
- Emergency Use - Investigational Drug Biologic (Doc 103)
- Engaged in Research - Definition (Doc 315)
- Exempt Procedures (Doc 26)
- Expedited Procedures (Doc 51)
- Expiration (Doc 91)
- Federal & State Law Differences (Doc 113)
- Finder's Fees & Enrollment Bonuses (Doc 54)
- HIPAA Waivers (Doc 214)
- HUD/HDE Policy (Doc 313)
- HUD Cover Letter (Doc 314)
- Human Subject Protection Program (Doc 2)
- Human Subject Research Definition (Doc 40)
- Incidental Findings
- Informed Consent - Additional Information (Doc 102)
- Informed Consent - Alterations & Waivers (Doc 104)
- Informed Consent - Responsibility of PI & IRB (Doc 10)
- Informed Consent Form Elements (Doc 300b)
- Informed Consent Process - Investigators (Doc 119)
- Informed Consent Process - Obtaining ICF (Doc 99)
- Infrastructure & Resources (Doc 25)
- IND/IDE Policy (Doc 53)
- Initial Review Materials (Doc 77)
- Investigational Drugs - Storing, Handling, & Dispensing (Doc 57)
- Investigational Test Article Use (Doc 52)
- Investigator Oversight (Doc 124)
- IRB Chair Criteria (Doc 65)
- IRB Meetings - Ensuring Quorum (Doc 218)
- IRB Member Attendance Policy (Doc 217)
- IRB Member Alternates
- IRB Members - Choosing Members for Review (Doc 61)
- IRB Minutes - Discussion Documentation (Doc 85)
- IRB Minutes Procedures
- Minimizing Risk (Doc 87)
- Mission Statement (Doc 1)
- NCI CIRB Protocol Receipt & Review (Doc 221)
- Non-Compliance (Doc 202)
- Notice of Inspection by Regulatory Agency
- Participant Safety Provisions (Doc 88)
- PI Credentials on Drug-Device Studies (Doc 317)
- Planned Emergency Research Policy (Doc 213)
- Prospective Participant Information (Doc 312)
- Protecting IRB from Undue Influence (Doc 39)
- Protecting Participants (Doc 118)
- Protecting Participants in Exempt Research (Doc 43)
- Protecting Privacy (Doc 95)
- Publication Rights (Doc 129)
- Quality Improvement Reviews (Doc 316)
- Quorum, Initial, Continuing, & Amendment Reviews (Doc 72)
- Radiation Safety Policy (Doc 32)
- Record Retention (Doc 84)
- Recordkeeping Requirements (Doc 83)
- Recruitment - Advertising (Doc 36)
- Reporting to Regulatory Agencies & Institutional Officials (Doc 206)
- Scientific Validity (Doc 8)
- Scientist & Non-Scientist Definition (Doc 215)
- Selecting Appropriate Reviewers (Doc 209)
- Sound Research Design (Doc 112)
- Sponsor Obligations-Issues (Doc 128)
- State & Local Laws (Doc 14)
- Subject Population (Doc 4)
- Termination/Suspension (Doc 122)
- Three Strikes Rule (Doc 311)
- Voluntary Suspension Policy (Doc 35)
- Vulnerable Populations (Doc 90)
- Withholding Medication (Doc 310)
- WVU HIPAA Policy (Doc 98)
